Monoclonal antibodies directed to CD52
Details for Australian Patent Application No. 2011223547 (hide)
International Classifications
Event Publications
1 November 2012 PCT application entered the National Phase
PCT publication WO2011/109662 Priority application(s): WO2011/109662
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2011223559-Evaluating noise and excess current on a power line
2011223542-Compounds useful for treating neurodegenerative disorders
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser